[1] Amsterdam EA, Wenger NK, Brindis RG, et al.2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2014, 130(25): 2354-2394. [2] Fang C, Ren X, Zhou H, et al.Effects of eNOS rs1799983 and ACE rs4646994 polymorphisms on the therapeutic efficacy of salvianolate injection in Chinese patients with coronary heart disease[J]. Clin Exp Pharmacol Physiol, 2014, 41(8): 558-564. [3] Meng C, Zhuo XQ, Xu GH, et al.Protection of salvianolate against atherosclerosis via regulating the inflammation in rats[J]. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(5): 646-651. [4] Zhao Q, Peng Y, Huang K, et al.Salvianolate Protects Hepatocytes from Oxidative Stress by Attenuating Mitochondrial Injury[J]. Evid Based Complement Alternat Med, 2016, 2016:5408705. [5] 中华医学会心血管病学分会.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367. [6] 李林,吴龙飞,刘芙蓉,等.丹参多酚酸盐治疗急性心肌梗死疗效的研究[J].中国循证心血管医学杂志,2015,7(3):317-319. [7] 何训,吕世文,郭佳奕.丹参多酚酸盐治疗冠心病的临床疗效及安全性[J].中国临床药理学杂志,2016,32(2):105-107. [8] 刘俊田. 动脉粥样硬化发病的炎症机制的研究进展[J].西安交通大学学报(医学版),2015,36(2):141-152. [9] Turan T, Mentese U, Agac MT, et al.The relation between intensity and complexity of coronary artery lesion and oxidative stress in patients with acute coronary syndrome[J]. Anatol J Cardiol, 2015, 15(10): 795-800. [10] Esterbauer H, Schaur RJ, Zollner H.Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes[J]. Free Radic Biol Med, 1991, 11(1):81-128. |